Institutional investors control 0.17% of the outstanding shares in NVGN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2013, these large investors purchased a net $11.1 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TOWER RESEARCH CAPITAL LLC Bought 2.3 Thousand shares of Novogen Ltd
BALTIMORE-WASHINGTON FINANCIAL A... Bought 1.1 Thousand shares of Novogen Ltd
UBS SECURITIES LLC Bought 228.00 shares of Novogen Ltd